LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 7,250 | 5,706 | 5,703 | 4,395 | 4,184 |
| Cost of Goods | 787 | 554 | 551 | 500 | 1,200 |
| Gross Profit | 6,463 | 5,152 | 5,152 | 3,895 | 2,984 |
| Operating Expenses | 32,356 | 32,518 | 33,917 | 34,064 | 46,610 |
| Operating Income | -25,106 | -26,812 | -28,214 | -29,669 | -43,426 |
| Interest Expense | 2,376 | 2,863 | 2,806 | 2,729 | 2,723 |
| Other Income | 2,249 | 501 | 604 | 713 | 731 |
| Pre-tax Income | -25,233 | -29,174 | -30,416 | -31,685 | -45,418 |
| Net Income Continuous | -25,233 | -29,174 | -30,416 | -31,685 | -45,418 |
| Net Income | $-25,233 | $-29,174 | $-30,416 | $-31,685 | $-45,418 |
| EPS Basic Total Ops | -0.93 | -1.08 | -1.12 | -1.17 | -1.68 |
| EPS Basic Continuous Ops | -0.93 | -1.08 | -1.12 | -1.17 | -1.67 |
| EPS Diluted Total Ops | -0.93 | -1.08 | -1.12 | -1.17 | -1.68 |
| EPS Diluted Continuous Ops | -0.93 | -1.08 | -1.12 | -1.17 | -1.67 |
| EBITDA(a) | $-23,624 | $-24,698 | $-27,081 | $-28,539 | $-42,266 |